Sargramostim After Bone Marrow Transplantation in Treating Patients With Myelodysplastic Syndrome

Clinical trial NCT00003961 · COMPLETED

Trial details

NCT number: NCT00003961
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Leukemia Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases

Start date: 1999-04-01
Primary completion: 2007-12-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.